Home›Companies›Healthcare›Synapticure

Synapticure, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 24, 2024·Suggest an edit

About Synapticure

Synapticure is a private company based in Chicago, Illinois, incorporated in 2019 in Delaware. It has reported $40,145,500 raised in one offering on Form D since September 2024. Its chief executive is Sandra Abrevaya.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 9, 2024Sep 24, 2024$40,145,500fully sold51$787KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Synapticure's Form D filed Sep 24, 2024.

SA
Sandra Abrevaya
Chief Executive Officer and director
AS
BW
PW
Peter Wallach
Executive officer
JL
Joe Leinbach
Executive officer
JL
EA
Eric Anderson
Executive officer

Sources

  1. SECSynapticure, Inc. filing history